Results 301 to 310 of about 1,303,960 (381)
Hidden Cardiovascular Risk: Arterial Stiffness and Left Ventricular Remodeling as Potential Indicators of Masked Hypertension. [PDF]
Zhu C+5 more
europepmc +1 more source
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo+10 more
wiley +1 more source
Assessment of oxidative balance score with hypertension and arterial stiffness in children and adolescents: NHANES 2001-2018. [PDF]
Wang C+6 more
europepmc +1 more source
Abstract Chronic kidney disease (CKD) and chronic heart failure (HF) frequently coexist and, when comorbid, are associated with poorer outcomes. These two diseases have common risk factors, such as diabetes, obesity and hypertension, and common pathophysiological connected mechanisms, including inflammation, endothelial dysfunction, neurohormonal ...
Johann Bauersachs+2 more
wiley +1 more source
Childhood Blood Pressure Control in Relation to Arterial Stiffness in Adulthood. [PDF]
Jones L, Shantsila A.
europepmc +1 more source
The Arteriograph : measuring axillo-brachial rather than aortic stiffness? [PDF]
De Buyzere, Marc+7 more
core
Immuno‐haemostatic dysregulation in heart failure with preserved ejection fraction
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex condition with partially unclear pathophysiology, in which systemic inflammation is a central contributor to changes in cardiac structure and function. The contribution of non‐traditional immune effectors—such as platelets and coagulation—remains underexplored in HFpEF ...
Giorgia D'Italia+13 more
wiley +1 more source
Analysis of the Sex-Specific Risk Factors for Arterial Stiffness. [PDF]
Yuan J+7 more
europepmc +1 more source
This systematic review identified 24 clinical trials of medical device and surgical interventions for HFpEF, with 16 demonstrating at least safety and feasibility, but little evidence of long‐term benefit. Phenotype‐based responses suggest that certain interventions may benefit specific HFpEF subgroups, yet most trials suffered from heterogeneous ...
Kurdo Araz+5 more
wiley +1 more source
Usefulness of Arterial Stiffness as an Integrated Marker of Cardiovascular Risk. [PDF]
Prado G+10 more
europepmc +1 more source